ArticleAnnals of intensive care2023

Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial.

Ignacio Martin-Loeches et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.